Pharma Stocks Get Hit As Biden Weighs In… Plus Tesla’s Delivery Beat 7/2/24

This podcast episode explores the pressure faced by pharmaceutical companies due to high drug pricing, the complexities involved in pricing drugs, the reasons behind the differences in drug prices between the US and other countries, the growing support for drug negotiations in Medicare, and the potential impact of lower drug prices on the upcoming election. It also discusses the performance of retail and consumer stocks, the fluctuation of crude oil prices, and the challenges and skepticism surrounding Tesla's RoboTaxi technology. Additionally, the struggles faced by homebuilders and the weakness in the homebuilder industry are mentioned.

Outlines

Sign in to continue reading, translating and more.

Open full episode in Podwise

CNBC's "Fast Money"

Pharma Companies Face Pressure Over High Drug Pricing Ahead of the Election

The Complexity of Drug Pricing and Political Rhetoric

Discrepancies in Drug Prices: The Role of Middlemen and Lack of Transparency

The Shift Towards Supporting Drug Negotiations in Medicare for Cost Reduction and Transparency

Competing in the Alzheimer's Market: Lilly and Biogen Take the Lead

Political Influence and Investment Landscape in the Healthcare Industry

Retail Stocks Struggle While Some Consumer Names See Gains

Investor Sentiment and Consumer Stocks: Are Investors Becoming Cautious?

Crude Oil Prices Fluctuate as Fed Chair Powell Talks Inflation Fight

Q2 Results and the Hype Surrounding Tesla's RoboTaxi Unveil

The Potential Challenges of Tesla's Robotaxi and Chinese Competition

Mixed News for Tesla and Homebuilders: Struggles and Weakness in the Market

Weakness in Home Builders due to Rate Cut Expectations and Regional Exposure

Pharma Stocks Get Hit As Biden Weighs In… Plus Tesla’s Delivery Beat 7/2/24

CNBC's "Fast Money"

00:00Pharma Companies Face Pressure Over High Drug Pricing Ahead of the Election

Pharma Companies Face Pressure Over High Drug Pricing Ahead of the Election

03:42The Complexity of Drug Pricing and Political Rhetoric

The Complexity of Drug Pricing and Political Rhetoric

06:54Discrepancies in Drug Prices: The Role of Middlemen and Lack of Transparency

Discrepancies in Drug Prices: The Role of Middlemen and Lack of Transparency

10:11The Shift Towards Supporting Drug Negotiations in Medicare for Cost Reduction and Transparency

The Shift Towards Supporting Drug Negotiations in Medicare for Cost Reduction and Transparency

14:27Competing in the Alzheimer's Market: Lilly and Biogen Take the Lead

Competing in the Alzheimer's Market: Lilly and Biogen Take the Lead

17:14Political Influence and Investment Landscape in the Healthcare Industry

Political Influence and Investment Landscape in the Healthcare Industry

20:44Retail Stocks Struggle While Some Consumer Names See Gains

Retail Stocks Struggle While Some Consumer Names See Gains

24:52Investor Sentiment and Consumer Stocks: Are Investors Becoming Cautious?

Investor Sentiment and Consumer Stocks: Are Investors Becoming Cautious?

27:42Crude Oil Prices Fluctuate as Fed Chair Powell Talks Inflation Fight

Crude Oil Prices Fluctuate as Fed Chair Powell Talks Inflation Fight

31:19Q2 Results and the Hype Surrounding Tesla's RoboTaxi Unveil

Q2 Results and the Hype Surrounding Tesla's RoboTaxi Unveil

34:41The Potential Challenges of Tesla's Robotaxi and Chinese Competition

The Potential Challenges of Tesla's Robotaxi and Chinese Competition

38:05Mixed News for Tesla and Homebuilders: Struggles and Weakness in the Market

Mixed News for Tesla and Homebuilders: Struggles and Weakness in the Market

42:27Weakness in Home Builders due to Rate Cut Expectations and Regional Exposure

Weakness in Home Builders due to Rate Cut Expectations and Regional Exposure